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Summary
Efﬁcient optimization of microbial processes is a
critical issue for achieving a number of sustainable
development goals, considering the impact of micro-
bial biotechnology in agrofood, environment, bio-
pharmaceutical and chemical industries. Many of
these applications require scale-up after proof of
concept. However, the behaviour of microbial sys-
tems remains unpredictable (at least partially) when
shifting from laboratory-scale to industrial condi-
tions. The need for robust microbial systems is thus
highly needed in this context, as well as a better
understanding of the interactions between ﬂuid
mechanics and cell physiology. For that purpose, a
full scale-up/down computational framework is
already available. This framework links computa-
tional ﬂuid dynamics (CFD), metabolic ﬂux analysis
and agent-based modelling (ABM) for a better under-
standing of the cell lifelines in a heterogeneous envi-
ronment. Ultimately, this framework can be used for
the design of scale-down simulators and/or metaboli-
cally engineered cells able to cope with environmen-
tal ﬂuctuations typically found in large-scale
bioreactors. However, this framework still needs
some reﬁnements, such as a better integration of
gas–liquid ﬂows in CFD, and taking into account
intrinsic biological noise in ABM.
Bioprocess scale-up/down: historical perspectives
and computational framework
Scale-up of fermentation processes in the biotech indus-
try is a critical step in bringing bioprocess and bioproduct
innovations to commercialization. This step is notorious
for performance losses and delays in development. The
scale-down approach has been advocated as a smart
way to minimize these issues. In principle, this approach
consists of four interconnected activities:
i Detailed analysis of the large-scale conditions, charac-
terizing the dynamic environment witnessed by the
microorganisms;
ii As precise as possible translation of this environment
to the laboratory-scale, via design of scale-down simu-
lators;
iii Tests at laboratory-scale under conditions representa-
tive for large scale to ﬁnd better combinations of
strains and environmental conditions;
iv Back-translation of successful ﬁndings (e.g. more
robust strains, less variable environments) to the large
scale.
Already in the 1980s, beneﬁts of the scale-down
approach have been demonstrated (Oosterhuis, 1983;
Sweere and Mesters, 1988), although at that time, the
level of precision was limited. Later on, early computa-
tional approaches (Euler–Euler modelling methods) have
been added to capture large-scale process details with
higher resolution (Larsson et al., 1996; Enfors et al.,
2001), also reﬁning the scale-down simulator design. One
major step forward then was the introduction of computa-
tional methods that use the perspective from the microbial
viewpoint, that is describing the lifelines of individual cells
on their journey through the large-scale bioreactor (Lapin
et al., 2004). This is referred to as Euler–Lagrange or
agent-based modelling (ABM). In more recent years, the
continuously advancing computer power and better insight
into metabolic dynamics have enabled major resolution of
the reactor content, in hundreds of thousands location
points, with lifelines of millions individual cells (Haringa
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et al., 2017; Haringa et al., 2016). Today, this presents an
opening to a different way of bioprocess engineering, not
anymore based on gross simpliﬁcation, but rather on brute
force simulations of reality including much of its complex-
ity.
Sound scale-up/down strategies rely heavily on accu-
rate description of the phenomena at the various scales.
Hereby, it should be realized that the environment of the
microorganisms changes drastically when scaling up or
down (Oosterhuis, 1983). This is inherent to the ﬂuid
dynamics involved: the larger the scale, the more promi-
nent the inﬂuence of turbulence. As ﬂuid mechanics and
in particular turbulence are nonlinear phenomena, a
straightforward strategy cannot be formulated. Mixing of
nutrient feeds, shear rates, mass transfer and transport
of the microorganisms through the reactor are all inﬂu-
enced by the ﬂow and turbulence. Computational ﬂuid
dynamics (CFD) addresses all these issues (Sweere
and Mesters, 1988; Larsson et al., 1996). With this com-
putational approach, we can accurately simulate the ﬂuid
ﬂow in the reactor and track nutrient mixing. Moreover,
we can simulate the journeys of a large number (105–
107) of microorganisms through the bioreactor. In this
way, we are able to study large-scale fermentation pro-
cesses through the eyes of the microorganisms (Enfors
et al., 2001), taking into account the wide spread in
scales in liquid ﬂow, concentration gradients of nutrients
and oxygen and can even assess the effect of cooling
coils and other internals if needed. Furthermore, the
effect of changes in the local surroundings of the
microorganisms can be coupled to the performance of
the cells, for example in terms of substrate uptake,
growth and (by)-product formation. To this end, compact
reaction kinetic (CRK) models are used to keep track of
the pools of the most important species inside the cell.
In summary, this allows a coupling of the processes
inside the cells in response to the ‘turbulent environment’
that they experience over time (Lapin et al., 2004).
The basic idea of CFD is to solve the equations of
motion of the ﬂuid in the reactor (i.e. the Navier–Stokes
equations). These equations describe conservation of
mass and the balance of momentum in the ﬂuid. In partic-
ular, the momentum balance is of a nonlinear nature,
which prohibits analytical solutions for virtually all practical
ﬂows. This requires discretizing the mathematical equa-
tions and solving them numerically. However, there is a
serious catch: when scaling up, the ﬂow becomes more
turbulent and a feature of turbulent ﬂows is a wide span of
scales both in space and in time. This span goes up so
quickly when increasing the turbulence, that for industrial
size equipment, even our biggest computers are not large
enough to deal with it. Therefore, only the dominant scales
in the ﬂow are computed, while the small scales are mod-
elled using a turbulence model (Haringa et al., 2017).
Once this is established, the microorganisms can be
tracked during their motion through the reactor (Figure 1).
This is done in a Lagrangian way: a large collection of indi-
vidual cells is tracked in the ﬂowing liquid. Because the
ﬂuid is simulated as a continuum and the microorganisms
as particles, this method is called Euler–Lagrange simula-
tion. Enfors et al. (2001) pioneered this approach for
industrial bioreactors. The organisms are so small that the
drag forces exerted by the ﬂuid completely govern their
motion. Consequently, the microorganisms follow the
motion of the ﬂuid. But there is another catch here: only
the large scale of the ﬂow ﬁeld is known. The effect of the
smaller structures (i.e. all smaller scale eddies in the ﬂuid)
needs to be put in the simulation via a modelling
approach. This is, for example, done via random walk
approaches: the small-scale structures act like a kind of
diffusion on the motion of the microorganisms. This means
that cells that would start at exactly the same location at
exactly the same time would not follow the same trajec-
tory. The consequence is that every time when a new
position of a cell is computed (based on the computed
ﬂuid ﬂow), a random side step is added that mimics the
effect of the turbulence. By storing the positions of the
cells as function of time, the ‘lifeline’ of each simulated cell
is recorded (Enfors et al., 2001; Haringa et al., 2016;
Kuschel et al., 2017).
The CFD approach outlined above results in tracking the
positions of all simulated cells in the reactor as a function
of time. At the same time, the local environment of each cell
at each time is also computed. In the second step, the
external world of the cell is coupled to the internal space in
a dynamic, local way. The cell takes up nutrients and, pos-
sibly, oxygen depending on the local driving forces. More-
over, the cells inﬂuence the local driving forces via nutrient
uptake. Finally, a cell has the ability to store metabolites
and macromolecules (e.g. trehalose, glycogen) and thus
survive periods of local starvation providing that it returns
back to nutrient-rich zones in sufﬁcient time. This means
that the internal metabolic processes should be simulated
at the same time scale as the external mixing and trans-
port. Currently, it is not possible to do that all from ﬁrst prin-
ciples. Luckily, that is also not needed. The ﬂuid(s) ﬂow
ﬁeld can be computed separately and serve as frozen input
to the species and cell transport coupled to the internal
metabolic processes. The reason for this is that the cells
can be considered as tracers that do not modify the ﬂow
ﬁeld (Oosterhuis et al., 1985).
From dry-laboratory to wet-laboratory approach:
designs and applications of scale-down simulators
Despite the logic of the scale-down approach, novel
bioprocesses are still often developed and optimized
ﬁrst in small-scale bioreactors (1–30 L) before they are
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transferred into large-scale industrial conditions. In addi-
tion, rigorous modelling or computation approaches are
scarce. Laboratory-scale data represent the most impor-
tant experimental proof for the performance of the pro-
cess. Titres, productivities, product/substrate conversion
efﬁciencies, product purities, etc., are not only used to
design up- and downstream processing units but also
to deﬁne the operating window of economic success in
large-scale production. The performance of laboratory-
scale fermentations usually deﬁnes the economic
expectations of the industrial process. Any kind of
large-scale underperformance compared to the design
criteria may push the process out of the economic
operation window and may render it non-viable. To
increase the probability of success, tools to predict
large-scale performance either by simulating industrial
conditions in so-called scale-down wet-laboratory simu-
lators or by dry-laboratory simulation of large-scale per-
formance are highly welcome, but by and large these
tools are not much applied, and certainly not in a quan-
titative way. The question is whether design of scale-
down simulators based on qualitative reasoning or with-
out reference to large-scale details makes sense for
scale-up research. At best perhaps, worst case options
can be studied.
Stirred tank reactors (STR) represent the state of
the art for wet-laboratory tests. This may seem surpris-
ing considering that very large bioreactors are prefer-
ably designed as bubble columns or airlift reactors
(L€ubbert, 2000). However, laboratory-scale STRs are
regarded as ideally mixed subunits that can be linked
together to mimic different metabolic regimes that are
formed as a result of the circulation paths of cells
entering and leaving different zones of large-scale
bioreactors (Figure 2).
First examples were published by Oosterhuis and Kos-
sen (1983) and Oosterhuis et al. (1985) applying the
STR-STR set-up for investigating the impact of different
oxygen supplies in each STR. Gluconobacter oxydans
was cycled between zones with high and low oxygen
availability. Similar approaches were published by Lara
et al. (2005), Lara et al. (2009) and recently by Kass
et al. (2014) and Limberg et al. (2017) studying Escheri-
chia coli and Corynebacterium glutamicum respectively.
Alternatively, STR-STR set-ups could be operated in the
so-called master–slave mode, that is the ‘master’ reactor
may be operated in fed-batch mode sending control val-
ues of fermentation conditions to the ‘slave’ (or ‘satellite’)
reactor. While running in parallel, the ‘satellite’ was
labelled with 13C glucose thereby enabling detailed ﬂux
pattern analysis as a mirror of the ‘master’ performance
(El Massaoudi et al., 2003). Similar set-ups are also
applied in industry to test impact of media components
during piloting. Recently, a reactor cascade consisting of
a main 100 L STR and two 1 L STRs arranged in a loop
of the main reactor was published (Buchholz et al.,
2014). Different partial pressures of dissolved CO2 were
installed in the loop bioreactors to monitor fast transcrip-
tional and metabolic responses to different CO2 pres-
sures which occur in large-scale production.
Fig. 1. Computational framework used for scaling-up/down studies. A concentration gradient ﬂow ﬁeld is simulated based on the numerical res-
olution of the Navier–Stokes equations based on a Eulerian reference. Cell trajectories can be simulated with the same model translated in a
Lagrangian reference. Superposition leads to a cell lifelines distribution. An agent-based model incorporating a relevant metabolic network is
ﬁnally needed for the precise simulation of the environmental impact on the state of individual cells. The panel showing the Lagrangian refer-
ence has been adapted from Kuschel et al. (2017).
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Probably, the most classical set-up consists of an STR
and a plug-ﬂow reactor installed in the loop of the STR.
Gradients of substrates are imposed on cells cycling
through the PFR with residence times that mirror large-
scale mixing conditions. First examples were published by
George et al. (1993) and Neubauer et al. (1995) investi-
gating the impact of oscillating glucose supply on Saccha-
romyces cerevisiae and Escherichia coli respectively. The
set-up is frequently applied by various groups typically sim-
ulating phenotypic performance of fed-batch cultivations
(Junne et al., 2011). Recently, the STR-PFR approach
was applied in continuous mode using the steady state
without PFR as a reference for quantifying short- and long-
term transcriptional and metabolic responses of E. coli
(Lofﬂer et al., 2017; Simen et al., 2017). Furthermore, the
concept of STR-PFR has been expanded to STR-PFR-
PFR by integrating a second PFR loop to ﬁne tune the rep-
resentation of multiple zones inside a large-scale bioreac-
tor (Lemoine et al., 2015). Whereas the aforementioned
scale-down devices needed external units to impose large-
scale stress conditions, Schilling et al. (1999) integrated
perforated plates in an STR-BIC (built-in components)
approach for deteriorating the mixing between different
reactor zones. STR-RS (rapid sampling) devices are used
to monitor the short-term metabolic dynamics after pertur-
bations that mirror stimuli of large-scale inhomogeneities.
Observed metabolic dynamics serve for model identiﬁca-
tion ﬁnally to allow model-predicted large-scale perfor-
mance (Tang et al., 2017). Stimuli may be imposed either
internal or external of the STR. Cell sampling must be done
rapidly accompanied by a fast inactivation of cellular meta-
bolism. Examples of rapid sampling devices comprise
heat exchangers (Theobald et al., 1993), frozen tubes
(Weuster-Botz, 1997), automated transportation belts
(Schaefer et al., 1999), the BioScope technique (Visser
et al., 2002) and many others.
In more recent scale-down studies, omics-based
technologies have been applied with the aim to eluci-
date the physiological mechanisms responsible for loss
of performance in large-scale cultivation systems. In
order to identify sets of ‘signature transcripts’ to monitor
the nutritional status and possible stress conditions in
large-scale fermentations of Saccharomyces cerevisiae,
transcriptome studies have been carried out under
well-deﬁned conditions in aerobic and anaerobic che-
mostats under different nutrient limitations (C, N, P, S)
(Boer et al., 2003; Tai et al., 2005). They identiﬁed a
set of 155 speciﬁcally oxygen-responsive genes and
several sets speciﬁc for different macronutrient limita-
tions. Transcriptome measurements have also been
applied to investigate the physiological effects of dis-
solved oxygen gradients on recombinant E. coli in a
scale-down device (Lara et al., 2009). The measured
transcriptional changes explained the observed alter-
ations in stoichiometry and kinetics, as well as produc-
tion of ethanol and organic acids. The observed
differences in transcription levels between aerobic and
anaerobic compartments of the scale-down device indi-
cated that E. coli responds rapidly to dissolved oxygen
gradients.
Proteomic proﬁling of recombinant E. coli in high-cell-
density fermentations revealed distinct physiological
changes during the cultivation, for example synthesis of
the phage shock protein A (PspA) appeared strongly
correlated with product synthesis (Aldor et al., 2005).
Controlled coexpression of PspA resulted in improve-
ment of the product yield.
Metabolomics and protein measurements were applied
to study the negative effect of substrate gradients on
antibiotic production in Penicillium chrysogenum (de
Jonge et al., 2011). To this end, feast–famine experi-
ments were carried out in an intermittently fed chemo-
stat. These conditions resulted in oscillations in
intracellular adenosine nucleotide levels, possibly affect-
ing the in vivo activity of L-a-(d-aminoadipyl)-L-a-cystei-
nyl-D-a-valine synthase (ACVS): the ﬁrst enzyme of the
penicillin biosynthesis pathway. In further feast–famine
experiments, 13C-based ﬂuxomics and metabolomics
Fig. 2. Scale-down devices using the stirred tank reactor (STR) as an ideally mixed compartment connected to other STRs or plug-ﬂow reac-
tors (PFR). Built-in components (BIC) to reduce homogeneity also have been applied. Furthermore, large-scale stimuli can be reﬂected in STR
and monitored in rapid sampling (RS) approaches.
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revealed that substrate gradients resulted in extremely
large oscillations in intermediates of central carbon meta-
bolism and simultaneous synthesis and degradation of
storage carbohydrates, resulting in additional ATP dissi-
pation (de Jonge et al., 2014).
Exometabolome measurements were carried out to
investigate the physiological effects of scale-up of a
high-density fed-batch process of S. cerevisiae (Fu
et al., 2014) which revealed reduced oxygen
availability at large scale resulting in overﬂow metabo-
lism. Combined metabolome and proteome analysis
indicated that hypoxia caused lower productivity upon
scale-up of a CHO bioprocess (Gao et al., 2016).
Proteome, transcriptome and metabolome analyses
were carried out by Limberg et al. (2017) to identify the
metabolic key mechanisms responsible for the tolerance
of Corynebacterium glutamicum to oxygen and substrate
gradients. The applied multiomics approach showed the
metabolic ﬂexibility of this organism to deal with inhomo-
geneities in large-scale processes.
In these omics-based approaches, the effects of
scale-up conditions on the physiology of the whole cul-
ture have been investigated; however, an additional
aspect to be considered is possible heterogeneity of the
culture itself, requiring single-cell-based techniques.
A step forward: taking into account microbial
individuality
Despite several efforts made at the experimental and
computational level, bioprocess scale-up/down is not only
a tale of ﬂuid mechanics and metabolite ﬂuxes. Indeed,
the microbial population itself is able to exhibit different
diversiﬁcation strategies. Phenotypic diversiﬁcation natu-
rally occurs in the environment (even under stable condi-
tions) where this phenomenon typically leads to increased
ﬁtness of the whole microbial population (Martins and
Locke, 2015), but also occurs in bioprocesses (Grun-
berger et al., 2014; Delvigne et al., 2014). Intracellular
biochemical reactions are intrinsically noisy, considering
the relatively low number of molecules involved (Hilﬁnger
and Paulsson, 2011), leading to potential phenotypic
heterogeneity in different microbial production hosts, for
example through cell-to-cell variation in promoter expres-
sion, unequal transporter distribution and bet-hedging fol-
lowing a diauxic shift (Binder et al., 2017). The fact that
the microbial cell is intrinsically noisy has not yet been
taken into account in the actual scale-up/down computa-
tional framework (Lemoine et al., 2017). In practice, only a
part of the extrinsic component of noise is actually taken
into account by linking cell trajectories with effective meta-
bolic ﬂuxes distribution (Figure 1).
As for scale-up/down studies, microbial population anal-
ysis relies both on computational and on experimental
approaches. Experimental investigation of microbial phe-
notypic diversiﬁcation in bioprocesses involves mainly the
use of automated ﬂow cytometry (Brognaux et al., 2013;
Broger et al., 2011) or real-time imaging in combination
with tailored microﬂuidic cultivation devices (Grunberger
et al., 2012; Dusny et al., 2012). Linking experimental sin-
gle-cell studies with in silico approaches allows for a better
interpretation of microbial individuality in bioprocesses. As
an example, automated ﬂow cytometry has been used for
validating a biological scaling law, linking protein expres-
sion to promoter noise in process-related conditions (Baert
et al., 2015). Stochastic simulation of intracellular bio-
chemical reactions can be achieved through the use of the
Gillespie algorithm (Gillespie, 1977), in a way that can be
assimilated to an agent-based model (ABM). Incorporating
microbial individuality in the scale-up/down computational
framework could thus be achieved through the existing
ABM (Figure 3). Indeed, stochastic processes can be
directly incorporated in ABM (Hellweger et al., 2016). Such
an approach has been used recently for simulating the
dynamics of the E. coli tryptophan operon in a scale-down
reactor. The Gillespie algorithm representing trp-depen-
dent protein synthesis was directly incorporated in the
ABM for this purpose (Niess et al., 2017).
Scale-up/down tools enable successful industrial
implementation of microbial bioprocesses
The thorough application of the aforementioned tools
provides a highly valuable (big) data basis mirroring the
cellular responses to typical large-scale stimuli. Data
should be used to derive and validate proper models for
in silico and ab initio prediction of large-scale perfor-
mances. Notably, these approaches are a useful tool to
reduce manpower and money for tedious scale-up tests
during piloting or even directly in production facilities.
Recent examples of lifeline analysis (Haringa et al.,
2016; Kuschel et al., 2017) should encourage similar
applications in the future.
Predictions for large-scale performance may be
exploited in different ways: on the one hand, one may
derive design criteria for the process or the bioreactor
set-up to prevent non-wanted performance losses. On
the other hand, detailed scale-up studies may be used
to engineer production strains such that non-changeable
process heterogeneities do no longer alter the perfor-
mance of the cells. Recently, Michalowski et al. (2017)
succeeded to engineer E. coli HGT which – among
others – has the inherent property of constant intracellu-
lar ppGpp pools. ppGpp, the alarmone of the stringent
response, is typically produced under glucose or nitro-
gen (ammonia) limitation. Accordingly, the stringent
response is immediately induced when cells face short-
age, as it may frequently occur in poorly mixed
ª 2017 The Authors. Microbial Biotechnology published by John Wiley & Sons Ltd and Society for Applied Microbiology.
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bioreactor zones. Strains with a constant ppGpp pool
interrupt the intracellular signal transduction which
makes them ‘blind’ for external changes. In addition,
transcriptional dynamics as observed by Lofﬂer et al.
(2016) may be further exploited to identify frequently
changing gene expressions with no apparent function for
productivity. Those may serve as deletion candidates for
saving expression energy thereby reducing the mainte-
nance demand of the cells.
The rigorous application of these novel scale-up con-
cepts offers a series of economic beneﬁts. Savings may
occur (i) while transferring the process faster from the lab
to the production, (ii) by achieving better performance in
large scale and (iii) by reducing operation and investment
costs for large-scale fermenters (Noorman and Heijnen,
2017).
Regarding (i), considering that piloting or production
tests often cost 40 000–80 000 €/run, one may easily cal-
culate total savings assuming that the usual number of
tests ranging from 10–15 reduces to 2–3 instead. Coinci-
dentally, development times should be cut tremendously,
because checks in piloting facilities often hamper the
speed of bioprocess development. The proportional reduc-
tion of development times seems to be reasonable. Perfor-
mance losses according to (ii) comprise not only less
efﬁcient substrate-to-product conversion but also increas-
ing impurities in the fermentation broth and reduced
amounts of product per batch. All factors deteriorate the
economic success of the product. Their cumulative effect
may easily sum up to 25%–50% of manufacturing costs on
average. Accordingly, applying modern tools for scale-up
can secure the economic survival of the new process. Con-
sidering (iii), the use of robust production strains with dis-
tinct qualities for large-scale application further allows to
reduce OPEX (expenses for operation) and CAPEX (ex-
penses for investment) likewise. Often, energy costs for
mixing, mass transfer and cooling represent more than
10% of manufacturing costs in aerobic processes. Appar-
ently, this fraction can be reduced if strains tolerate hetero-
geneities better than they do today. By analogy,
investments in engines, compressors, pumps, gearing and
stirrers may be reduced which will be reﬂected in product
cost estimation by reduced depreciation. The latter typi-
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